ALZ-301

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameALZ-301
Drug Alias Namebeta amyloid 40 oligomer targeted replacement peptide (Alzinova)ALZ-301
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlzinova AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlzinova AB
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A